Geoff needs to go

Quote




anonymous said:
The company plans to announce its earnings on August 20, 2024. In that report, analysts expect Medtronic to post earnings of $1.20 per share. This would mark no growth from the year-ago period - YAHOO Finance


Excellent work!
I’m sure GM will have plenty of excuses why the company is not doing well; the jet needs an upgrade and growth sectors need fewer engineers in the R&D department to bring bottom line earnings up.
Click to expand...
But, he's accomplishing all his DEI goals. Go woke, go broke
 




Remember this gem from 2020? Way to go Geoff you really stuck the landing didn’t you:

“
Headline:
Brace Yourself for a More Competitive Medtronic
snippet:
Medtronic is "finding a new gear," and becoming a more nimble and competitive organization, according to CEO Geoff Martha.
"And in the coming weeks, you're going to hear more from me on this topic, as we begin to outline the new Medtronic," Martha said this week during the company's earnings call, which covered the first quarter of Medtronic's fiscal year 2021, according to Seeking Alpha transcripts of the call.”
 




anonymous said:
Remember this gem from 2020? Way to go Geoff you really stuck the landing didn’t you:

“
Headline:
Brace Yourself for a More Competitive Medtronic
snippet:
Medtronic is "finding a new gear," and becoming a more nimble and competitive organization, according to CEO Geoff Martha.
"And in the coming weeks, you're going to hear more from me on this topic, as we begin to outline the new Medtronic," Martha said this week during the company's earnings call, which covered the first quarter of Medtronic's fiscal year 2021, according to Seeking Alpha transcripts of the call.”
Click to expand...
It’s all hot air and has been for a decade. Name one acquisition including Covidien that has paid itself back, let alone it being profitable, There hasn’t been one and I’m not sure there will ever be another one moving forward for MDT. Our leadership knows that we no longer make great products which are innovative which need a top flight sales force to push them…they are now trying to offset that with going from A players in the field to B to now C players hoping that somehow paying less for salespeople will make everything work in their world of fake numbers. It won’t. Get out while you can. If you are an A player trying to find a really good gig in this field…it is like finding a needle in a haystack, it’s time to move to a different industry. Industries of service, not products, is where it’s at. Infinite growth and opportunity without the constant issues of manufacturing costs which inevitably leads to increase costs, backorders, quality issues, and then lawsuits.….repeat. Medtronic is up against the wall, and wall street knows it.
 




Good luck trying to find anyone in their 20s that can talk to a doctor

Just because they have a BME degree does not mean they can sell a customer

They might work for $75K but they are getting nowhere in the field

Coupled with so many products under advisory and shit leadership, it is easy to see how they are no longer the market leader
 




I was a Sr manager with MDT for over 10 years. The exec committee has created such a toxic environment and destroyed the company culture that the only people not looking for other opportunities are those at the very top with the golden parachutes. Geoff got too wrapped up in DEI and it's taken a heavy toll by putting the wrong people in key positions because they fit a profile criteria.
 




anonymous said:
I was a Sr manager with MDT for over 10 years. The exec committee has created such a toxic environment and destroyed the company culture that the only people not looking for other opportunities are those at the very top with the golden parachutes. Geoff got too wrapped up in DEI and it's taken a heavy toll by putting the wrong people in key positions because they fit a profile criteria.
Click to expand...
Here we go, another bitch whining about DEI.
 




















Seriously???? Racism has nothing to do here.

This is pure incompetence by a CEO that was clueless about the acquisition of COV, which he was in charge, clueless about running a BU ( which he had never done before, thanks Omar) and drove Spine YOY revenue down every year but one ( go look it up) and has been looking for a new higher gear for 4 years now, while stock has imploded as the peer group has increase sales and market share.

This board is absolutely asleep at the wheel and borders on malfeasance. Geoff should have been let go 2 years ago.

Wake up board!!

Activist shareholders,,,,wake up!!
 
















Top Bottom
Back
Quote